Cartesian Therapeutics, Inc. Annual Interest Expense in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Cartesian Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2014 to 2023.
  • Cartesian Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $0.000, a 100% decline year-over-year.
  • Cartesian Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $2.03M, a 35.3% decline year-over-year.
  • Cartesian Therapeutics, Inc. annual Interest Expense for 2023 was $2.83M, a 6.53% decline from 2022.
  • Cartesian Therapeutics, Inc. annual Interest Expense for 2022 was $3.03M, a 6.58% increase from 2021.
  • Cartesian Therapeutics, Inc. annual Interest Expense for 2021 was $2.84M, a 82.8% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.83M -$198K -6.53% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $3.03M +$187K +6.58% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $2.84M +$1.29M +82.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-07
2020 $1.56M +$37K +2.44% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 $1.52M +$25K +1.67% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-10
2018 $1.49M +$288K +23.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
2017 $1.21M -$47K -3.75% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $1.25M +$305K +32.2% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-15
2015 $948K +$396K +71.7% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
2014 $552K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.